| Literature DB >> 30987320 |
Yara Saleh1, Sébastien Antherieu2, Romain Dusautoir3, Laurent Y Alleman4, Jules Sotty5, Corentin De Sousa6, Anne Platel7, Esperanza Perdrix8, Véronique Riffault9, Isabelle Fronval10, Fabrice Nesslany11, Ludivine Canivet12, Guillaume Garçon13, Jean-Marc Lo-Guidice14.
Abstract
Exposure to particulate matter (PM) is leading to various respiratory health outcomes. Compared to coarse and fine particles, less is known about the effects of chronic exposure to ultrafine particles, despite their higher number and reactivity. In the present study, we performed a time-course experiment in mice to better analyze the lung impact of atmospheric ultrafine particles, with regard to the effects induced by fine particles collected on the same site. Trace element and PAH analysis demonstrated the almost similar chemical composition of both particle fractions. Mice were exposed intranasally to FF or UFP according to acute (10, 50 or 100 µg of PM) and repeated (10 µg of PM 3 times a week during 1 or 3 months) exposure protocols. More particle-laden macrophages and even greater chronic inflammation were observed in the UFP-exposed mice lungs. Histological analyses revealed that about 50% of lung tissues were damaged in mice exposed to UFP for three months versus only 35% in FF-exposed mice. These injuries were characterized by alveolar wall thickening, macrophage infiltrations, and cystic lesions. Taken together, these results strongly motivate the update of current regulations regarding ambient PM concentrations to include UFP and limit their emission.Entities:
Keywords: (sub)chronic exposure; Ultrafine particles; inflammation; lung tissue remodeling; mice
Mesh:
Substances:
Year: 2019 PMID: 30987320 PMCID: PMC6479904 DOI: 10.3390/ijerph16071210
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Experimental protocol of acute and subchronic exposures of mice to FF and UFP. Particles were suspended in 40 µL of HBSS. In the acute exposure, mice were sacrificed (S) 24 h after receiving a single dose of particles (10, 50 or 100 µg). For the subchronic exposure, the mice were exposed 3 times a week for 1 or 3 months to 10 µg of particles. Control mice received HBSS without particles. Arrows pointing down mean intranasal instillations of a dose of HBSS, FF or UFP.
Figure 2Size and number distribution of particle suspensions in HBSS used in the acute and subchronic exposure protocols. (a) FF solution (n = 3). (b) UFP solution (n = 3). FF solution revealed the presence of 1265 ± 239 nm particles. However, the UFP solution revealed the presence of two peaks. The first peak corresponded to ultrafine particles of 188.0 ± 39.9 nm. The second (1078 ± 305 nm) was correlated to particles aggregates formed in the samples.
Elemental composition of FF and UFP quantified by ICP-MS. Values are the mean of measurements carried out on three sub-samples representative of the initial sample.
| Element (µg/g) | FF | UFP |
|---|---|---|
| As | 23.0 | 64.8 |
| Ba | 140.3 | 64.4 |
| Be | 0.4 | 0.3 |
| Cd | 16.9 | 19.3 |
| Ce | 8.5 | 6.3 |
| Co | 5.4 | 9.3 |
| Cs | 4.4 | 8.9 |
| Cu | 367.0 | 425.2 |
| La | 8.4 | 3.1 |
| Mn | 1350.4 | 582.2 |
| Mo | 25.6 | 36.7 |
| Ni | 98.7 | 199.7 |
| Pb | 399.4 | 541.9 |
| Rb | 26.3 | 44.1 |
| Sb | 47.1 | 49.3 |
| Sn | 49.6 | 111.1 |
| Sr | 91.8 | 49.3 |
| Ti | 3.0 | 5.7 |
| Zn | 4000.2 | 2460.7 |
| Cr | 97.3 | 120.7 |
| V | 75.0 | 196.3 |
| Al | 5252.2 | 3621.1 |
| Ca | 17,904.5 | 11,857.4 |
| Fe | 16,406.1 | 10,267.0 |
| K | 1240.3 | 30,368 * |
| Mg | 6591.3 | 6344.8 * |
| Na | 43,510.8 | 283,147 * |
| Si | 9383.5 | 7568.1 |
* Values not considered in the analysis due to their high amount in HBSS.
PAH composition of FF and UFP quantified by HPLC-Fluorimetry.
| PAH (ng/mg) | FF | UFP |
|---|---|---|
| Fluoranthene (FLA) | 5.1 | 4.3 |
| Pyrene (PYR) | 4.2 | 3.7 |
| Benzo(c)phenanthrene (BcPHE) | 0.4 | 0.2 |
| Benzo(a)anthracene (BaA) | 6.9 | 4.2 |
| Chrysene (CHR) | 6.8 | 2.8 |
| 5-Methylchrysene (5MCHR) | 1.1 | 3.4 |
| Benzo(e)pyrene (BeP) | 9.9 | 0.8 |
| Benzo(b)fluoranthene (BbF) | 7.6 | 8.0 |
| Benzo(j)fluoranthene (BjF) | 4.7 | 9.9 |
| Benzo(k)fluoranthene (BkF) | 7.4 | 4.6 |
| Benzo(a)pyrene (BaP) | 3.8 | 5.3 |
| Dibenzo(a,l)pyrene (DalP) | 0.8 | 0.4 |
| Dibenzo(a,h)anthracene (DahA) | 2.6 | 1.5 |
| Benzo(g,h,i)perylene (BghiP) | 12.0 | 12.5 |
| Indeno(1,2,3-c,d)pyrene (IP) | 14.0 | 12.1 |
| Dibenzo(a,e)pyrene (DaeP) | 3.6 | 2.7 |
| Anthanthrene (ANTH) | 0.1 | 3.3 |
| Coronene (COR) | 2.9 | 4.5 |
|
|
|
|
Values are the mean of measurements carried out on three sub-samples representative of the initial sample.
Figure 3Internalization of particles in lungs. (a) Representative micrographs of BAL cells of mice exposed for three months and histogram showing BAL cell count of particle-laden macrophages; M = macrophage, PLM = particle-laden macrophage, PNN = Polynuclear Neutrophil. (b) Tissue micrographs of lung tissue (40×); Arrow heads point out particle-laden macrophages. * p ≤ 0.05 vs Control; ** p ≤ 0.01 vs Control; *** p ≤ 0.001 vs Control; # p ≤ 0.05 vs FF.
Figure 4Inflammatory response analysis in BAL of mice exposed to FF and UFP. Histograms show BAL cell count in BAL of mice exposed for 24 h, 1 or 3 months: total cellularity, total number of PNN, total number of macrophages; n = 5 per condition; * p ≤ 0.05 vs Control; ** p ≤ 0.01 vs Control; *** p ≤ 0.001 vs Control; # p ≤ 0.05 vs FF.
Lung mRNA analysis of Cyp1a1, Cyp1b1, Il-6, Il-1b and il-10 in mice exposed to FF or UFP for 24 h, 1 month or 3 months.
| Acute Exposure | ||||||
|---|---|---|---|---|---|---|
| FF 10 | FF 50 | FF 100 | UFP 10 | UFP 50 | UFP 100 | |
|
| 0.8 ± 0.5 | 1.2 ± 0.6 | 1.7 ± 0.5 * | 0.8 ± 0.5 | 1.4 ± 0.4 | 1.7 ±0.5 * |
|
| 1.3 ± 0.3 | 1.6 ± 0.5 | 2.6 ± 1.6 ** | 0.9 ± 0.4 | 0.9 ± 0.2 | 2.2 ±1.0 * |
|
| 2.3 ± 2.5 | 1.3 ± 1.1 | 1.7 ± 1.9 | 1.8 ± 0.9 | 2.7 ±1.9 | 6.1 ±4.1 * |
|
| 0.7 ± 0.3 | 1.0 ± 0.3 | 0.8 ± 0.1 | 1.3 ± 0.2 | 1.7 ± 0.8 | 2.7 ± 1.2 |
|
| 1.1 ± 0.6 | 1.6 ± 0.5 | 1.0 ± 0.4 | 1.0 ± 0.7 | 1.6 ± 0.6 | 1.7 ± 0.8 |
|
|
| |||||
|
|
|
|
| |||
|
| 7.8 ± 4.2 ** | 3.5 ± 2.6 ** | 5.6 ± 2.0 ** | 1.8 ± 0.6 | ||
|
| 1..9 ± 0.2 | 1.6 ± 1.1 | 2.7 ± 0.9 * | 3.9 ± 2.2 ** | ||
|
| 0.4 ± 0.2 ** | 0.4 ± 0.1 * | 2.5 ± 1.6 | 7.8 ± 2.9 * | ||
|
| 1.1 ± 0.6 | 0.9 ± 0.2 | 0.7 ± 0.1 | 1.0 ± 0.3 | ||
|
| 0.4 ± 0.2 | 0.5 ± 0.1 | 2.2 ± 1.9 | 3.9 ± 1.0 * | ||
Data are presented as mean values and standard deviations. Gene expressions were calculated by the relative expression ratio of each gene to Ppia. n = 5; * p ≤ 0.05; ** p ≤ 0.01 vs control.
Figure 5Lung tissue remodeling following exposure to FF or UFP after 1 or 3 months. (a–f) Lung histology (hematoxylin and eosin stain) showing alveolar wall thickening in mouse lungs; Cyst = cystic region; magnification 10×. (g–l) Immunohistochemical staining of mouse lungs; representative images of lung tissue sections stained for F4/80 (macrophages are stained brown); magnification 40×.
Summary of histological lung changes following sub-chronic exposure to particles.
| 1 Month | 3 Months | |||||
|---|---|---|---|---|---|---|
| HBSS | FF | UFP | HBSS | FF | UFP | |
|
| 0 ± 0 | 0.7 ± 0.6 | 0.7 ± 0.6 | 0 ± 0 | 1 ± 0.0 | 1.7 ± 0.6 |
|
| 45.3 ± 16.3 | 275 ± 81.8 | 342.7 ± 74.4 | 53 ± 12.0 | 211 ± 122.7 | 500 ± 213.7 |
|
| 0 ± 0 | 1.3 ± 0.6 | 0.7 ± 0.6 | 0 ± 0 | 1.3 ± 0.6 | 1.7 ± 0.6 |
|
| 0.7 ± 0.6 | 1.7 ± 0.6 | 1.7 ± 0.6 | 1.0 ± 0 | 1.7 ± 0.6 | 2.3 ± 0.6 |
|
| 0.6 ± 0.8 | 5.5 ± 1.0 | 9.8 ± 2.0 | 1.8 ± 0.8 | 21.9 ± 9.0 | 28.3 ± 3.8 |
|
| 78.3 ± 4.3 | 66.3 ± 9.1 | 56.5 ± 8.4 | 64.8 ± 7.7 | 68.3 ± 14.0 | 61.7 ± 14.1 |
|
| 0.8 ± 0.9 | 8.3 ± 0.4 | 18 ± 6.6 | 2.7 ± 0.9 | 35 ± 21.2 | 47.3 ± 11.5 |
Peribronchiolar inflammation and cystic region scoring: None = 0, light = 1, moderate = 2, marked = 3, severe = 4. Total macrophages were counted in 10 high power fields (HPF) for each mouse. Alveolar wall thickness was determined by comparing the thickness of alveoli wall to the size of an erythrocyte (E): <1 E = 0; 1 to 2 E = 1; 3 to 5 E = 2; 6 to 10 E = 3; and >10 E = 4. The percentage of lesioned areas represents the distribution of thickened parenchyma surface to overall lung surface. HPF: high power field = 400.